OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+25.61%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$154M
AUM Growth
+$154M
Cap. Flow
+$11M
Cap. Flow %
7.18%
Top 10 Hldgs %
99.51%
Holding
13
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

1
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$12.7M

Top Sells

1
EDIT icon
Editas Medicine
EDIT
$1.07M
2
CDTX icon
Cidara Therapeutics
CDTX
$391K
3
FGEN icon
FibroGen
FGEN
$239K

Sector Composition

1 Healthcare 81.77%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$50.1M 32.54% 2,600,410 – –
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
$27.3M 17.73% 1,229,512 – –
FGEN icon
3
FibroGen
FGEN
$47.8M
$20M 13.02% 812,492 -9,683 -1% -$239K
EGLT
4
DELISTED
Egalet Corporation
EGLT
$14.7M 9.58% 2,889,926 – –
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$13.8M 8.94% 1,145,890 – –
JNCE
6
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$12.7M 8.29% +579,650 New +$12.7M
EPIX icon
7
ESSA Pharma
EPIX
$11.4M
$5.3M 3.44% 1,696,969 – –
PVLA
8
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$4.41M 2.87% 1,697,384 – –
CDTX icon
9
Cidara Therapeutics
CDTX
$1.66B
$3.47M 2.26% 444,965 -50,085 -10% -$391K
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$1.3M 0.84% 301,477 – –
DRNA
11
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$760K 0.49% 223,457 – –
EDIT icon
12
Editas Medicine
EDIT
$231M
– – -66,162 Closed -$1.07M
TARA icon
13
Protara Therapeutics
TARA
$120M
– – 0 – –